Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Hebei Changshan Biochemical Pharmaceutical (300255)
- 39.59
- -0.51-1.27%
Market Closed Apr 24 15:00 CST
36.39BMarket Cap-120.70P/E (TTM)
40.00High39.05Low126.75KlotVolume39.68Open40.10Prev Close501.04MTurnover1.38%Turnover RatioLossP/E (Static)919.06MShares71.7152wk High23.98P/B36.33BFloat Cap20.2352wk Low48.12Limit Up917.70MShs Float71.71Historical High32.08Limit Down2.37%Range %1.83Historical Low--Dividend TTM39.53Avg Price57.26KlotAsk--Div Yield TTM100Lot Size64.08KlotBid
Hebei Changshan Biochemical Pharmaceutical (300255) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -13.11%681.22M | -13.42%491.61M | -12.10%258.7M | -26.92%1.03B | -31.20%784.02M | -30.79%567.78M | -41.36%294.32M | -39.63%1.41B | -36.47%1.14B | -28.45%820.37M |
| Operating revenue | -13.11%681.22M | -13.42%491.61M | -12.10%258.7M | -26.92%1.03B | -31.20%784.02M | -30.79%567.78M | -41.36%294.32M | -39.63%1.41B | -36.47%1.14B | -28.45%820.37M |
| Other operating revenue | ---- | 128.87%11.83M | ---- | 149.38%33.04M | ---- | 10.57%5.17M | ---- | 37.31%13.25M | ---- | 3.76%4.68M |
| Total operating cost | -12.50%764.79M | -14.52%547M | -26.13%262.35M | -37.81%1.25B | -39.29%874.01M | -32.37%639.95M | -30.08%355.15M | -13.06%2.01B | -16.03%1.44B | -11.46%946.28M |
| Operating cost | -10.84%572.81M | -12.07%420.14M | -23.28%198.94M | -20.88%864.82M | -18.10%642.45M | -5.89%477.79M | -14.36%259.32M | -15.82%1.09B | -13.39%784.47M | -7.63%507.7M |
| Operating tax surcharges | 21.42%9.59M | 18.18%6.83M | -1.41%2.83M | -36.55%13.37M | -54.43%7.9M | -56.52%5.78M | -68.32%2.87M | -4.33%21.07M | 9.13%17.34M | 1.54%13.29M |
| Operating expense | -64.22%15.38M | -65.43%10.44M | -70.93%5.17M | -80.96%90.02M | -87.66%42.99M | -87.07%30.2M | -81.49%17.78M | -22.94%472.84M | -30.34%348.42M | -26.98%233.58M |
| Administration expense | -14.73%76.76M | -14.43%51.99M | -32.41%24.28M | -21.72%130.32M | -20.07%90.02M | -19.18%60.76M | -0.56%35.93M | 25.04%166.47M | 6.31%112.62M | 3.10%75.17M |
| Financial expense | -2.28%65.68M | -9.51%41.76M | -8.24%20.93M | 8.92%101.24M | -11.84%67.21M | -0.70%46.15M | -10.31%22.81M | -1.38%92.94M | 6.88%76.24M | 2.26%46.47M |
| -Interest expense (Financial expense) | -0.31%68.49M | 4.94%48.92M | 12.87%21.33M | 6.65%102.83M | -11.23%68.7M | -4.28%46.62M | -18.20%18.9M | 3.62%96.41M | 11.74%77.39M | 11.64%48.71M |
| -Interest Income (Financial expense) | 44.66%-1.4M | 35.70%-1.07M | 0.37%-384.45K | -104.04%-3.76M | -78.24%-2.53M | -44.18%-1.66M | 37.53%-385.86K | 7.65%-1.84M | -13.26%-1.42M | -48.21%-1.15M |
| Research and development | 4.82%24.57M | -17.83%15.85M | -37.95%10.2M | -70.29%47.19M | -76.69%23.44M | -72.48%19.29M | -57.26%16.44M | 9.52%158.82M | -12.88%100.56M | 3.42%70.07M |
| Credit Impairment Loss | 1,254.96%7.2M | 1,586.33%6.95M | 747.38%5.49M | 24.58%-19.55M | 25.75%531.49K | -137.79%-467.41K | -153.06%-848.41K | -175.27%-25.92M | 145.06%422.67K | 498.73%1.24M |
| Asset Impairment Loss | 937.29%14.43M | --11.84M | ---- | 88.97%-69.83M | 101.15%1.39M | ---- | ---- | -5,380.77%-633.32M | ---121.35M | ---51.32M |
| Other net revenue | -11.13%28.89M | -21.93%21.83M | 401.45%6.57M | 94.00%-37.9M | 130.60%32.51M | 175.16%27.96M | -88.90%1.31M | -6,682.34%-631.55M | -1,631.00%-106.24M | -1,289.87%-37.21M |
| Invest income | --1.67M | ---- | ---- | 473,418.78%33.26M | ---- | ---- | ---- | --7.02K | ---- | ---- |
| Asset deal income | 951.97%17.64K | 951.97%17.64K | ---- | -1,004.13%-63.3K | ---2.07K | ---2.07K | ---- | 152.67%7K | ---- | ---- |
| Other revenue | -81.80%5.57M | -89.36%3.03M | -50.27%1.07M | -33.94%18.28M | 108.24%30.59M | 120.85%28.43M | -78.84%2.16M | 137.08%27.68M | 86.16%14.69M | 272.72%12.87M |
| Operating profit | 4.88%-54.68M | 24.09%-33.55M | 104.90%2.91M | 79.28%-254.04M | 85.85%-57.48M | 72.90%-44.21M | -1,134.67%-59.52M | -6,095.95%-1.23B | -571.28%-406.28M | -301.66%-163.11M |
| Add:Non operating Income | -98.24%609.75K | -43.64%659.34K | 653.55%603.01K | 792.75%1.64M | 26,174.62%34.6M | 2,365.80%1.17M | 759.62%80.02K | -13.92%184.17K | 951.98%131.7K | 601.72%47.44K |
| Less:Non operating expense | -89.64%272.2K | -90.21%246.29K | 18.15%81.96K | -15.73%4.68M | 236.07%2.63M | 810.17%2.52M | 289.53%69.37K | 117.79%5.55M | -68.91%781.98K | -57.78%276.47K |
| Total profit | -113.06%-54.34M | 27.24%-33.14M | 105.77%3.44M | 79.13%-257.08M | 93.73%-25.5M | 72.11%-45.55M | -1,136.02%-59.51M | -6,898.82%-1.23B | -586.15%-406.93M | -303.57%-163.34M |
| Less:Income tax cost | 14.88%2.64M | 127.42%3.08M | -27.53%1.81M | -57.76%6.95M | 119.19%2.3M | 163.02%1.35M | -51.88%2.5M | 106.77%16.46M | -153.36%-11.99M | -111.50%-2.15M |
| Net profit | -104.93%-56.98M | 22.78%-36.22M | 102.62%1.63M | 78.85%-264.03M | 92.96%-27.81M | 70.90%-46.91M | -11,198.61%-62.01M | -12,389.70%-1.25B | -744.91%-394.94M | -361.83%-161.19M |
| Net profit from continuing operation | -104.93%-56.98M | 22.78%-36.22M | 102.62%1.63M | 78.85%-264.03M | 92.96%-27.81M | 70.90%-46.91M | -11,198.61%-62.01M | -12,389.70%-1.25B | -744.91%-394.94M | -361.83%-161.19M |
| Less:Minority Profit | 65.33%-12.17M | -225,634.22%-7.13M | -532.44%-2.16M | -83.23%-14.55M | -431.00%-35.1M | 99.94%-3.16K | 91.44%-340.82K | -7.96%-7.94M | -9.25%-6.61M | -66.25%-5.31M |
| Net profit of parent company owners | -714.77%-44.82M | 37.98%-29.09M | 106.13%3.78M | 79.88%-249.48M | 101.88%7.29M | 69.91%-46.9M | -1,457.82%-61.67M | -7,181.47%-1.24B | -677.10%-388.33M | -340.70%-155.88M |
| Earning per share | ||||||||||
| Basic earning per share | -600.00%-0.05 | 40.00%-0.03 | 106.11%0.0041 | 80.00%-0.27 | 102.38%0.01 | 70.59%-0.05 | -1,469.39%-0.0671 | -6,850.00%-1.35 | -700.00%-0.42 | -342.86%-0.17 |
| Diluted earning per share | -600.00%-0.05 | 40.00%-0.03 | 106.11%0.0041 | 80.00%-0.27 | 102.38%0.01 | 70.59%-0.05 | -1,469.39%-0.0671 | -6,850.00%-1.35 | -700.00%-0.42 | -342.86%-0.17 |
| Other composite income | -12,779.26%-254.19K | -792.54%-276.75K | -70.86%-74.15K | 105.00%79.04K | 100.22%2K | 104.57%39.96K | 93.62%-43.4K | 63.68%-1.58M | 79.86%-928.53K | 75.63%-874.46K |
| Other composite income of parent company owners | -12,779.26%-254.19K | -792.54%-276.75K | -70.86%-74.15K | 105.00%79.04K | 100.22%2K | 104.57%39.96K | 93.62%-43.4K | 63.68%-1.58M | 79.86%-928.53K | 75.63%-874.46K |
| Total composite income | -105.86%-57.24M | 22.12%-36.5M | 102.50%1.55M | 78.88%-263.95M | 92.98%-27.8M | 71.08%-46.87M | -50,897.29%-62.05M | -21,647.93%-1.25B | -799.07%-395.87M | -379.54%-162.07M |
| Total composite income of parent company owners | -718.09%-45.07M | 37.34%-29.37M | 106.01%3.71M | 79.92%-249.4M | 101.87%7.29M | 70.10%-46.86M | -1,698.20%-61.71M | -9,538.15%-1.24B | -721.04%-389.26M | -356.25%-156.75M |
| Total composite income of minority owners | 65.33%-12.17M | -225,634.22%-7.13M | -532.44%-2.16M | -83.23%-14.55M | -431.00%-35.1M | 99.94%-3.16K | 91.44%-340.82K | -7.96%-7.94M | -9.25%-6.61M | -66.25%-5.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm